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Molecular confirmation of
invasive infection caused by
Chaetomium globosum
Identification of the causative organism in
invasive fungal infections is difficult.
Accurate and reliable diagnostic methods
are required in light of the increasing
incidence of emerging fungal infections.
1
We recently described a method for speciat-
ing fungi in formalin fixed, paraffin wax
embedded tissue sections.
2 DNA is extracted
using a modification of the protocol for the
TaKaRa DEXPAT
TM kit (TaKaRa
Biomedicals), with additional steps using
lyticase and ethanol precipitation.
2
Amplification of the DNA is performed using
panfungal primers and a method based on
that described by Einsele et al.
3 Identification
to species level can be achieved by Southern
hybridisation with a probe that binds
Aspergillus fumigatus, A flavus, and A versicolor.
Polymerase chain reaction products that do
not hybridise with this probe are subse-
quently identified by sequence analysis.
2
We have used this method to confirm the
diagnosis in the case of a patient with acute
myeloid leukaemia and pneumonia caused by
Chaetomium globosum. We previously reported
the details of this case and discussed the
associated diagnostic difficulties.
4 A com-
puted tomography chest scan revealed cavi-
tating lesions characteristic of an invasive
fungal infection in the right upper lobe and a
right lobectomy was performed. Histology
demonstrated branching hyphae invading
blood vessels that were ‘‘consistent with
aspergillus’’. However, many filamentous
fungi resemble aspergillus species histologi-
cally, and identification relies on culturing
the organism from the tissue. In this case,
C globosum was cultured from the tissue
specimen and identified six weeks later, by
which time the patient had died. Moreover,
such microbiological identification cannot
differentiate between environmental contam-
ination and causative organisms.
Immunohistochemical staining of the tissue
was subsequently carried out using a mono-
clonal antibody directed specifically against
A fumigatus, A flavus, and A niger. Results were
negative, confirming that the infection was
not caused by these common aspergillus
species. Chaetomium globosum is a rare patho-
gen but a common contaminant, so we were
left with a presumptive diagnosis.
We have now achieved a definitive, mole-
cular diagnosis of an invasive fungal infec-
tion caused by C globosum in this case using
the method described above. Sections from
the original paraffin wax embedded tissue
were cut with a sterile microtome blade and
two 10 mm thick sections were subjected to
DNA extraction, after discarding the outer
section. A positive result was obtained after
polymerase chain reaction amplification with
panfungal primers, but subsequent hybridi-
sation with the aspergillus specific probe
yielded a negative result. The DNA was
purified using WizardH PCR Preps DNA
purification system (Promega, Madison,
Wisconsin, USA), according to the manufac-
turer’s instructions. The DNA was commer-
cially sequenced (Cytomyx, Cambridge, UK),
after which sequence analysis was performed
with the EMBOSS software package (HGMP-
RC; Medical Research Council, UK). The
sequence was identified as C globosum using
a BLAST search of Genbank and EMBL
nucleotide sequence databases and subse-
quently submitted to the EMBL database
(accession number AJ781794).
The C globosum isolate had been added to
the UK National Collection of Pathogenic
Fungi as NCPF 7115. We subcultured this
isolate then extracted, purified, and
sequenced the genomic DNA. The sequence
was identical to that of the DNA extracted
from the tissue sample, confirming the
causative role of this organism in our case.
With the growing population of immuno-
compromised patients and the broadening
spectrum of antifungal agents available it is
imperative that we can accurately identify the
organisms causing invasive fungal infections.
This case illustrates the value of molecular
tools to enhance the diagnostic process. ;
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